We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$11.2B
AUM Growth
+$94.1M
Cap. Flow
-$92.7M
Cap. Flow %
-0.83%
Top 10 Hldgs %
77.28%
Holding
1,482
New
520
Increased
341
Reduced
150
Closed
461

Sector Composition

Rank Sector Weight
1 Financials 2.04%
2 Industrials 2.03%
3 Technology 2.03%
4 Healthcare 1.6%
5 Consumer Discretionary 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTCT icon
551
PTC Therapeutics
PTCT
$6.12B
$571K 0.01%
+18,665
New +$605K
RVMD icon
552
Revolution Medicines
RVMD
$44B
$571K 0.01%
14,701
-4,235
-22% -$158K
NTST
553
NETSTREIT Corp
NTST
$2.1B
$570K 0.01%
35,421
-3,489
-9% -$60K
AYI icon
554
Acuity Brands
AYI
$10.8B
$569K 0.01%
+2,355
New +$602K
CDNA icon
555
CareDx
CDNA
$2.42B
$568K 0.01%
36,588
+25,087
+218% +$303K
CRL icon
556
Charles River Laboratories
CRL
$12.8B
$568K 0.01%
+2,749
New +$623K
MAN icon
557
ManpowerGroup
MAN
$2.63B
$568K 0.01%
8,132
+1,735
+27% +$128K
ALGN icon
558
Align Technology
ALGN
$12.3B
$566K 0.01%
+2,346
New +$653K
GPOR icon
559
Gulfport Energy Corp
GPOR
$2.88B
$563K 0.01%
3,728
-354
-9% -$55.5K
W icon
560
Wayfair
W
$14.6B
$563K 0.01%
10,674
-6,049
-36% -$359K
EZPW icon
561
Ezcorp Inc
EZPW
$1.71B
$562K 0.01%
53,682
+18,444
+52% +$195K
ELAN icon
562
Elanco Animal Health
ELAN
$11.1B
$561K 0.01%
+38,902
New +$622K
GL icon
563
Globe Life
GL
$14.3B
$559K 0.01%
+6,793
New +$563K
WRBY icon
564
Warby Parker
WRBY
$3.27B
$556K 0.01%
+34,651
New +$512K
SMTC icon
565
Semtech
SMTC
$13B
$554K 0.01%
18,553
+7,390
+66% +$258K
RDWR icon
566
Radware
RDWR
$1.19B
$550K ﹤0.01%
+30,155
New +$551K
CRS icon
567
Carpenter Technology
CRS
$28.4B
$550K ﹤0.01%
+5,018
New +$482K
DHT icon
568
DHT Holdings
DHT
$3.02B
$550K ﹤0.01%
47,500
+35,429
+294% +$416K
THRM icon
569
Gentherm
THRM
$1.27B
$550K ﹤0.01%
+11,142
New +$576K
NBIX icon
570
Neurocrine Biosciences
NBIX
$16.6B
$548K ﹤0.01%
3,984
-2,146
-35% -$294K
NXPI icon
571
NXP Semiconductors
NXPI
$60.4B
$548K ﹤0.01%
+2,037
New +$525K
ENVX icon
572
Enovix
ENVX
$1.03B
$547K ﹤0.01%
40,418
+12,923
+47% +$108K
CARR icon
573
Carrier Global
CARR
$52.8B
$546K ﹤0.01%
+8,662
New +$532K
SLVM icon
574
Sylvamo
SLVM
$1.63B
$546K ﹤0.01%
+7,961
New +$525K
CHGG icon
575
Chegg
CHGG
$102M
$542K ﹤0.01%
171,655
+132,370
+337% +$658K

Similar funds

Brevan Howard Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Brevan Howard Capital Management held 1,482 positions worth $11.2B, up 0.85% from $11.1B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Brevan Howard Capital Management's Q2 2024 filing shows 520 new, 341 increased, 150 reduced and 461 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 750,000 shares worth $57.9M. The largest sale was Workday, an estimated $31.5M.

By sector, the portfolio is most concentrated in Financials at 2% of assets, up from 1.5% a quarter earlier, followed by Industrials and Technology.

  • Brevan Howard Capital Management's largest Q2 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 750,000 shares worth $57.9M.
  • Brevan Howard Capital Management added most to Apple in Q2 2024, an estimated $23.6M increase.
  • Brevan Howard Capital Management's biggest Q2 2024 reduction was Elastic, cutting an estimated $11.1M.
  • Brevan Howard Capital Management fully exited Workday in Q2 2024, selling an estimated $31.5M.
  • Brevan Howard Capital Management's ten largest holdings make up 77% of its $11.2B portfolio in Q2 2024.
  • Brevan Howard Capital Management opened 520 new positions and closed 461 in Q2 2024.
  • Brevan Howard Capital Management's portfolio value rose 0.85% quarter-over-quarter to $11.2B.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.